1. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophthalmia. Report of two cases in children. AmJDis Child. 1922;24: 526-533.
2.
2. Weston WL. What is erythema multiforme?PediatrAnn. 1996;25:106-109.
3.
3. Patterson R, Dykewicz MS, Gonzalzles A, et al. Erythema multiforme and Stevens-Johnson syndrome: descriptive and therapeutic controversy. Chest. 1990;98:331-336.
4.
4. Bystryn J. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders. Arch Dermatol. 1996;132:711-712.
5.
5. Roujeau J. The spectrum of StevensJohnson syndrome and toxic epidermal necrolysis: a clinical classification. JInvestDermatol. 1994;102:28S-30S.
6.
6. Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am JDermatopathol. 1997;19:127-132.
7.
7. Bianchine JR, Macaraeg PVJ, Lasagna L, et al. Drugs as etiologic factors in Stevens-Johnson syndrome. AmJMed. 1968;44:390-405.
8.
8. Revuz J, Penso D, Roujeau J-C, et al. Toxic epidermal necrolysis: clinical findings and prognostic factors in 87 patients. Arch Dermatol. 1987;123: 1160-1165.
9.
9. Weston WL, Morelli JG, Rogers M. Target lesions on the lips: childhood herpes simplex associated with erythema multiforme mimics StevensJohnson syndrome. J Am Acad Dermatol. 1997;37:848-850.
11. Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17 (suppl 1):S47-51.
12.
12. Stutman HR. Stevens-Johnson syndrome and Mycoplasma pneumoniae: evidence for cutaneous infection.J Pediatr.1987;111:845-847.
13.
13. Patterson R, Miller M, Kaglan M, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy. 1994;94:27-34.
14.
14. Kakourou T, Klontza D, Soteropoulou F, Kattamis C. Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children. Eur J Pediatr. 1997;156:90-93.
